Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.63
    -0.73 (-0.88%)
     
  • GOLD FUTURES

    2,336.20
    -5.90 (-0.25%)
     
  • DOW

    38,516.25
    +12.56 (+0.03%)
     
  • Bitcoin GBP

    52,170.90
    -1,469.00 (-2.74%)
     
  • CMC Crypto 200

    1,403.36
    -20.74 (-1.46%)
     
  • NASDAQ Composite

    15,752.39
    +55.75 (+0.36%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Endo International’s Specialty and Established Products in Q1

Endo International’s Specialty and Established Products in Q1

Endo International’s (ENDP) net interest expense increased from $111.9 million in Q1 2017 to $123.9 million in Q1 2018. While the company received an income tax benefit of $11.9 million in Q1 2017, it had an income tax expense of $15.49 million in Q1 2018. That led to an increase in its net loss from $173.83 million in Q1 2017 to $505.48 million in Q1 2018. That translated to a net loss per share of $2.26 in Q1 2018 compared to a net loss per share of $0.78 in Q1 2017.